CG347B

CAS No. 1598426-03-9

CG347B( —— )

Catalog No. M23696 CAS No. 1598426-03-9

CG347B is a selective inhibitor of HDAC6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 74 In Stock
5MG 69 In Stock
10MG 112 In Stock
25MG 201 In Stock
50MG 300 In Stock
100MG 417 In Stock
200MG 588 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CG347B
  • Note
    Research use only, not for human use.
  • Brief Description
    CG347B is a selective inhibitor of HDAC6.
  • Description
    CG347B is a selective inhibitor of HDAC6.
  • In Vitro
    HtrA1 is identified as a Cisplatin (HY-17394, CDDP) resistance-related gene in NSCLC cells, while CG347B shows no effect on normalized mRNA expression or protein level of HtrA1 in NCI-H460 (CDDP-resistant) cells.CG347B (200 nM; 48 h) slightly rescues the Foxp3 expression inhibition induced by IL-4 (15 ng/mL), indicating a potential inhibition happens on histone deacetylation in naive CD4+ T cells from WT B6 mice cultured under Treg-polarizing conditions (for 1-3 d).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1598426-03-9
  • Formula Weight
    283.33
  • Molecular Formula
    C16H17N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:249 mg/mL?(878.83 mM;?Need ultrasonic)
  • SMILES
    CCOC(c1cnc(NC2(CC2)c2ccccc2)nc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Christopher M. YATES. Metalloenzyme inhibitor compounds. WO2018165520A1.
molnova catalog
related products
  • 2-hexyl-4-Pentynoic ...

    2-hexyl-4-Pentynoic Acid, a valproic acid (VPA) derivatives, is a potent and robust HDACs inhibitor with IC50 value of 13 μM.

  • Givinostat hydrochlo...

    Givinostat hydrochloride is an inhibitor of HDAC with IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat hydrochloride exhibits anti-inflammatory, anti-angiogenic, and antineoplastic activities.

  • R306465

    R306465 (JNJ-16241199) is an orally active and selective class I histone deacetylase (HDAC 1) inhibitor with an IC50 of 3.3 nM.